Reducing Home Labs for Pediatric Patients With Solid Tumors: Impact of a Novel Clinical Practice Guideline on Safety, Cost, and Quality of Life

ABSTRACT Introduction For pediatric patients with solid tumors, the use of growth factors following chemotherapy evolved from daily filgrastim to pegylated filgrastim. Currently, post‐chemotherapy laboratory work is obtained to monitor for transfusion needs rather than count recovery. We implemented...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Catherine B. Wall, Jill A. MacDonald, Riley Garland, Allison F. O'Neill
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2025-10-01
Schriftenreihe:	Cancer Medicine
Schlagworte:	guidelines pediatric quality safety solid tumors
Online-Zugang:	https://doi.org/10.1002/cam4.71269
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!